We are not ‘psychiatrists’; 'The beauty of the asylum’; Challenges with false-positive urine drug screens
Current Psychiatry. 2016 March;15(3):23-24
February 23, 2016|Psychiatry
Author and Disclosure Information
Adegboyega Oyemade, MD, FAPA
Addiction Psychiatrist
Maryland Treatment Centers, Inc.
Baltimore, Maryland
References
1. Melanson SE, Snyder ML, Jarolim P, et al. A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse. J Anal Toxicol. 2012;36(3):201-206.
2. Jenkins AJ, Poirier JG 3rd, Juhascik MP. Cross-reactivity of naloxone with oxycodone immunoassays: implications for individuals taking Suboxone. Clin Chem. 2009;55(7):1434-1436.
